Aligos Therapeutics logo
Aligos Therapeutics ALGS
$ 39.7 3.52%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Aligos Therapeutics EV/EBITDA Ratio 2011-2024 | ALGS

Annual EV/EBITDA Ratio Aligos Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.41 -8.66 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.41 -8.66 -5.54